Abstract Introduction The onset of erectile dysfunction (ED) is attributed to organic and nonorganic factors that can mirror the state of an individual’s general health. Public health policies have the potential to leverage ED as a marker for non-communicable diseases that burden healthcare systems worldwide. Recognizing ED as an early warning sign facilitates reframing of public health policies to integrate preventive strategies, screening, and education campaigns. Objective This study aims to address the interconnectedness of men’s health issues with ED to reduce morbidity and enhance men’s quality of life. Methods We developed an expert consensus on addressing ED within the framework of public health policy, which requires an understanding of its multifaceted etiology and implications. We reviewed the epidemiology of ED, its association with systemic health conditions, and the imperative for public health policymakers to prioritize men’s sexual health as a window to overall well-being. Results Public health policies must advocate for comprehensive sexual health education that demystifies ED and encourages early medical consultation. Policy interventions should make recommendations for incorporating ED screening into routine health check-ups, subsidizing treatment options to enhance accessibility, promoting public awareness campaigns on the link between lifestyle factors and ED, and strengthening mental health support systems that recognize the psychological impact of ED. Conclusions ED, as an early detector of potential health threats, provides a unique opportunity for public health practitioners to broaden the scope of men’s health initiatives. By harnessing the predictive value of ED for more severe conditions, public health policies can galvanize an integrative health movement that promotes longevity and well-being for men, ultimately serving the community at large. Public health policies that acknowledge the sentinel role of ED offer a strategic entry point for addressing systemic health concerns, thus improving outcomes for individuals and populations. Disclosure Yes, this is sponsored by industry/sponsor: Viatris. Clarification: Industry initiated, executed and funded study. Any of the authors act as a consultant, employee or shareholder of an industry for: Viatris.
Read full abstract